Immune dysregulation and pharmacogenomics in neurodevelopmental disorders, part 1: a review of fixed versus dynamic immunophenotypes
Medical Research Archives · 2026
DOI: 10.18103/mra.2026.0766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Research Archives, 2026. Verfasst von Jeffrey L. Clothier und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Immune dysregulation recurs across neurodevelopmental disorders — autism spectrum disorder, attention-deficit/hyperactivity disorder, early-onset schizophrenia-spectrum, and obsessive-compulsive presentations — as one of the few mechanistic threads crossing a diagnostically heterogeneous territory. This review takes that convergence as established and asks a different question about it. The literature summarizes the finding as a single phenomenon, a chronic low-grade inflammatory tone, and that summary collapses a distinction the underlying mechanistic work does not support. The inflammatory state observed in these populations arises by at least two routes, differing not in magnitude and not reliably in cytokine profile, but in whether the process producing it is finished or continuing. The developmentally fixed route is constitutional — altered complement pathway activity, interferon receptor gene dosage, or the imprint of a discrete gestational exposure — established before any inflammatory episode and not fluctuating with current health. The dynamically maintained route is sustained by chronic stress, subclinical infection, gut-barrier disruption, or active autoimmune disease, producing an overlapping downstream profile through processes that intensify and remit with present circumstances. The two can stand in a causal relation as well as coexist: a constitutional immunophenotype can generate a dynamically maintained one. The distinction also carries a measurement consequence easily missed — the categories are not two levels of one variable but two kinds of quantity, inflammatory activity, which conventional acute-phase markers index well, and inflammatory responsiveness, which they do not capture at all. We trace the mechanism from maternal immune activation through the quad-partite synapse and its perineuronal net gate to disrupted cortical gamma oscillations, work the partition through Down syndrome, and set out the two-tiered study design that would test it.
Zitieren
APA
Clothier, J. L., & Harville, T. O. (2026). Immune dysregulation and pharmacogenomics in neurodevelopmental disorders, part 1: a review of fixed versus dynamic immunophenotypes. Medical Research Archives. https://doi.org/10.18103/mra.2026.0766
Vancouver
Clothier JL, Harville TO. Immune dysregulation and pharmacogenomics in neurodevelopmental disorders, part 1: a review of fixed versus dynamic immunophenotypes. Medical Research Archives. 2026. doi:10.18103/mra.2026.0766
BibTeX
@article{Clothier2026,
author = {Clothier, Jeffrey L. and Harville, Terry O.},
title = {Immune dysregulation and pharmacogenomics in neurodevelopmental disorders, part 1: a review of fixed versus dynamic immunophenotypes},
journal = {Medical Research Archives},
year = {2026},
doi = {10.18103/mra.2026.0766}
}
EUVIMED